Skip to main content
. 2020 Dec 14;20:427. doi: 10.1186/s12876-020-01573-9

Fig. 2.

Fig. 2

The platelet count in patients who received repeated lusutrombopag treatment (n = 13). ac The platelet count in patients who used lusutrombopag 2 or more times in all patients (n = 13) (a), group A (n = 9) (b), and group B (n = 4) (c). df The platelet count in patients who used lusutrombopag 3 or more times in all patients (n = 10) (d), group A (n = 7) (e), and group B (n = 3) (f). *p < 0.05, **p < 0.01. n.s not significant, LUS lusutrombopag